GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer

Clinical trial NCT00480025 · TERMINATED

Trial details

NCT number: NCT00480025
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer, Non-Small Cell

Start date: 2007-10-04
Primary completion: 2013-12-06
Enrollment: 2278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.